MAY KO: Open Payments
NPI 1528447653 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,751 in 138 payments from 23 companies in 2025. Trend: 2023 $3,900 · 2024 $4,726 · 2025 $3,751
Food & beverage: $3,676Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $922 |
| Janssen Biotech, Inc. | 20 | $524 |
| Amgen Inc. | 8 | $393 |
| PFIZER INC. | 14 | $352 |
| GENZYME CORPORATION | 11 | $213 |
| Arcutis Biotherapeutics, Inc. | 9 | $212 |
| UCB, Inc. | 7 | $157 |
| Botanix SB Inc | 4 | $143 |
| Journey Medical Corporation | 5 | $141 |
| Lilly USA, LLC | 5 | $136 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, LITFULO, Zoryve, Bimzelx, SOFDRA.
Industry payments across FL — which companies pay providers there.
